Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Keryx Biopharmaceuticals Inc (NASDAQ:KERX)

5.65
Delayed Data
As of Mar 24
 +0.13 / +2.36%
Today’s Change
4.03
Today|||52-Week Range
7.80
-3.58%
Year-to-Date
Keryx's Auryxia Added to Largest Medicare Part D Plan
Mar 22 / Zacks.com - Paid Partner Content
Keryx Focuses on Kidney Drug Aurexia Despite Generic Threat
Mar 16 / Zacks.com - Paid Partner Content